Skip to content
Open access · OA via Europe PMC

The NAD<sup>+</sup> challenge: Harnessing immune-mediated tumor control without fueling the enemy.

Zuiker E, Hemann EA, Long ME.

Molecular therapy. Oncology · 2026

Abstract

This 2026 Molecular Therapy Oncology article examines the role of NAD+ metabolism in regulating immune responses and tumor progression.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1016/j.omton.2026.201311
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
E, Z., EA, H., &amp; ME., L. (2026). The NAD&lt;sup&gt;+&lt;/sup&gt; challenge: Harnessing immune-mediated tumor control without fueling the enemy. <em>Molecular therapy. Oncology</em>. https://doi.org/10.1016/j.omton.2026.201311
Vancouver
E Z, EA H, ME. L. The NAD&lt;sup&gt;+&lt;/sup&gt; challenge: Harnessing immune-mediated tumor control without fueling the enemy. Molecular therapy. Oncology. 2026. doi:10.1016/j.omton.2026.201311.
BibTeX
@article{zuiker2026TheNAD, title = {The NAD&lt;sup&gt;+&lt;/sup&gt; challenge: Harnessing immune-mediated tumor control without fueling the enemy.}, author = {Zuiker E and Hemann EA and Long ME.}, journal = {Molecular therapy. Oncology}, year = {2026}, doi = {10.1016/j.omton.2026.201311}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings